首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells.
【24h】

The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells.

机译:抗菌肽天蚕素A和抗癌药对白血病细胞的联合作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Anti-microbial cecropins are humoral immune peptides originally found in insects. They possess a particular function of membrane permeabilization on both gram-positive and gram-negative bacteria. Yet, they are not capable of lysing eucaryotic cells. In this experiment, we confirmed that cecropin A (CA) is a special agent able to lyse leukemia cells while exerting little toxic effect on normal lymphocytes, based on the IC50 measurements. The therapeutic index of CA ranged from 6 to 17. In contrast, chemical anti-cancer agents (ACAs) are non-specific drugs capable of damaging both cancer and normal cells. Due to the functional differences between CA and ACAs, the experiments on the combined effects of CA and ACAs were conducted in vitro. Under certain conditions, synergistic effects were found with CA/S-FU and CA/Ara-C combinations. The results suggest the need for further study into the possible application of combining anti-cancer agents with antibacterial peptides for cancer treatment.
机译:抗菌天蚕素是最初在昆虫中发现的体液免疫肽。它们在革兰氏阳性和革兰氏阴性细菌上均具有特殊的膜通透性功能。然而,它们不能裂解真核细胞。在此实验中,我们根据IC50的测定结果确认了天蚕素A(CA)是一种能够溶解白血病细胞同时对正常淋巴细胞几乎没有毒性作用的特殊药物。 CA的治疗指数范围为6到17。相反,化学抗癌药(ACA)是能够破坏癌症和正常细胞的非特异性药物。由于CA和ACA之间功能上的差异,因此在体外进行了CA和ACA联合作用的实验。在某些条件下,发现CA / S-FU和CA / Ara-C组合具有协同作用。结果表明需要进一步研究将抗癌药与抗菌肽联合用于癌症治疗的可能应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号